1. Home
  2. ATAI vs MTA Comparison

ATAI vs MTA Comparison

Compare ATAI & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • MTA
  • Stock Information
  • Founded
  • ATAI 2018
  • MTA 1983
  • Country
  • ATAI Germany
  • MTA Canada
  • Employees
  • ATAI N/A
  • MTA N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • ATAI Health Care
  • MTA
  • Exchange
  • ATAI Nasdaq
  • MTA Nasdaq
  • Market Cap
  • ATAI 282.6M
  • MTA 267.2M
  • IPO Year
  • ATAI 2021
  • MTA N/A
  • Fundamental
  • Price
  • ATAI $1.41
  • MTA $2.98
  • Analyst Decision
  • ATAI Strong Buy
  • MTA Hold
  • Analyst Count
  • ATAI 3
  • MTA 1
  • Target Price
  • ATAI $10.50
  • MTA $4.50
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • MTA 351.7K
  • Earning Date
  • ATAI 05-19-2025
  • MTA 05-19-2025
  • Dividend Yield
  • ATAI N/A
  • MTA N/A
  • EPS Growth
  • ATAI N/A
  • MTA N/A
  • EPS
  • ATAI N/A
  • MTA N/A
  • Revenue
  • ATAI $308,000.00
  • MTA $5,882,000.00
  • Revenue This Year
  • ATAI $65.58
  • MTA $125.91
  • Revenue Next Year
  • ATAI N/A
  • MTA $58.98
  • P/E Ratio
  • ATAI N/A
  • MTA N/A
  • Revenue Growth
  • ATAI N/A
  • MTA 28.01
  • 52 Week Low
  • ATAI $1.03
  • MTA $2.32
  • 52 Week High
  • ATAI $2.57
  • MTA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • MTA 48.49
  • Support Level
  • ATAI $1.36
  • MTA $2.88
  • Resistance Level
  • ATAI $1.54
  • MTA $3.16
  • Average True Range (ATR)
  • ATAI 0.09
  • MTA 0.12
  • MACD
  • ATAI -0.00
  • MTA -0.01
  • Stochastic Oscillator
  • ATAI 0.00
  • MTA 21.51

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: